BioClinica, Inc. Announces Availability of Express EDCplus
4/22/2013 11:16:22 AM
More...
|
BioClinica, Inc. to Demonstrate Technology-Enhanced Capabilities at Upcoming Global Industry Events
4/3/2013 12:14:39 PM
More...
|
BioClinica, Inc. and JLL Partners Announce Early Termination of Hart-Scott-Rodino Act Waiting Period
2/22/2013 10:07:44 AM
More...
|
BioClinica, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results
2/7/2013 6:43:58 AM
More...
|
BioClinica, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results
2/6/2013 6:51:51 AM
More...
|
BioClinica, Inc. to Release Fourth Quarter and Year-End
2/4/2013 6:13:41 AM
More...
|
BioClinica, Inc. to be Bought by Private-Equity Firm JLL Partners for $123 Million, CoreLab Partners Also Part of Deal
1/30/2013 8:46:44 AM
More...
|
BioClinica, Inc. to Participate in Upcoming Industry Events and Demonstrate Global Technology–Enhanced Clinical Trial Management Capabilities
1/10/2013 6:18:50 AM
More...
|
BioClinica, Inc. to Present at the Sidoti Semi-Annual Micro-Cap Conference on January 7, 2013 in New York City
12/20/2012 6:10:45 AM
More...
|
BioClinica, Inc. Reports 15.7% Growth in Service Revenue and 26.1% Increase in Non-GAAP Operating Income for Third Quarter
11/8/2012 9:52:06 AM
More...
|
|